Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer
- Tuesday, April 12, 2022, 7:10
- Business
- Add a comment
Longtime clinical development leader will help advance pipeline of precision medicines for genetically defined neurological and immunological diseases, with initial focus on Parkinson’s disease SOUTH SAN FRANCISCO, Calif., April 12, 2022 /PRNewswire/ — Neuron23™ Inc., an early stage…
About the Author
adminasapcorp has written 41558 stories on this site.